IL6 and neoplasm: Although we did not detect any CB2-related differences in the number of macrophages in the spleen, we cannot rule out their possible involvement in the anti-tumorigenic role of CB2, e.g., by polarizing macrophages towards M1 macrophages (tumor promoting) or by limiting the expression of IL-6 and other chemokines [54,55,56].